Trial Profile
Effect of Sym004 in oesophageal cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2015
Price :
$35
*
At a glance
- Drugs Futuximab (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 09 Feb 2015 New trial record